OBJECTIVE: The peripheral myelin protein-22 (PMP22) gene is associated with the most common types of inherited neuropathies, including hereditary neuropathy with liability to pressure palsies (HNPP) caused by PMP22 deficiency. However, the function of PMP22 has yet to be defined. Our previous study has shown that PMP22 deficiency causes an impaired propagation of nerve action potentials in the absence of demyelination. In the present study, we tested an alternative mechanism relating to myelin permeability. METHODS: Utilizing Pmp22(+) (/) (-) mice as a model of HNPP, we evaluated myelin junctions and their permeability using morphological, electrophysiological, and biochemical approaches. RESULTS: We show disruption of multiple types of cell junction complexes in peripheral nerve, resulting in increased permeability of myelin and impaired action potential propagation. We further demonstrate that PMP22 interacts with immunoglobulin domain-containing proteins known to regulate tight/adherens junctions and/or transmembrane adhesions, including junctional adhesion molecule-C (JAM-C) and myelin-associated glycoprotein (MAG). Deletion of Jam-c or Mag in mice recapitulates pathology in HNPP. INTERPRETATION: Our study reveals a novel mechanism by which PMP22 deficiency affects nerve conduction not through removal of myelin, but through disruption of myelin junctions.
OBJECTIVE: The peripheral myelin protein-22 (PMP22) gene is associated with the most common types of inherited neuropathies, including hereditary neuropathy with liability to pressure palsies (HNPP) caused by PMP22deficiency. However, the function of PMP22 has yet to be defined. Our previous study has shown that PMP22deficiency causes an impaired propagation of nerve action potentials in the absence of demyelination. In the present study, we tested an alternative mechanism relating to myelin permeability. METHODS: Utilizing Pmp22(+) (/) (-) mice as a model of HNPP, we evaluated myelin junctions and their permeability using morphological, electrophysiological, and biochemical approaches. RESULTS: We show disruption of multiple types of cell junction complexes in peripheral nerve, resulting in increased permeability of myelin and impaired action potential propagation. We further demonstrate that PMP22 interacts with immunoglobulin domain-containing proteins known to regulate tight/adherens junctions and/or transmembrane adhesions, including junctional adhesion molecule-C (JAM-C) and myelin-associated glycoprotein (MAG). Deletion of Jam-c or Mag in mice recapitulates pathology in HNPP. INTERPRETATION: Our study reveals a novel mechanism by which PMP22deficiency affects nerve conduction not through removal of myelin, but through disruption of myelin junctions.
Authors: C S Gillespie; D L Sherman; S M Fleetwood-Walker; D F Cottrell; S Tait; E M Garry; V C Wallace; J Ure; I R Griffiths; A Smith; P J Brophy Journal: Neuron Date: 2000-05 Impact factor: 17.173
Authors: L Notterpek; K J Roux; S A Amici; A Yazdanpour; C Rahner; B S Fletcher Journal: Proc Natl Acad Sci U S A Date: 2001-11-20 Impact factor: 11.205
Authors: Yannick Poitelon; Vittoria Matafora; Nicholas Silvestri; Desirée Zambroni; Claire McGarry; Nora Serghany; Thomas Rush; Domenica Vizzuso; Felipe A Court; Angela Bachi; Lawrence Wrabetz; Maria Laura Feltri Journal: J Neurochem Date: 2018-02-13 Impact factor: 5.372
Authors: Carlos G Vanoye; Masayoshi Sakakura; Rose M Follis; Alexandra J Trevisan; Malathi Narayan; Jun Li; Charles R Sanders; Bruce D Carter Journal: J Biol Chem Date: 2019-06-18 Impact factor: 5.157